Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair. 

<p>Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair. </p>

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

<p>Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.</p>

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Merck CEO Rob Davis Talks Winrevair Approval

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c49ddae0-87db-4b34-94c8-b14101219399/transcript

Advertisement